Corticosterone administration up-regulated expression of norepinephrine transporter and dopamine β-hydroxylase in rat locus coeruleus and its terminal regions

Journal of Neurochemistry

Volumn 128, Issue 3, 2014, Pages 445-458

  Fan, Yan ^a   Chen, Ping ^a,b   Li, Ying ^a   Cui, Kui ^a   Noel, Daniel M ^c   Cummins, Elizabeth D ^c   Peterson, Daniel J ^c   Brown, Russell W ^c   Zhu, Meng Yang ^a  

^a East Tennessee State University   (United States)

^b TONGJI UNIVERSITY   (China)

^c EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

animal behavior; corticosterone; dopamine hydroxylase; locus coeruleus; norepinephrine transporter; rat brain

Indexed keywords

CORTICOSTERONE; DOPAMINE BETA MONOOXYGENASE; MESSENGER RNA; MIFEPRISTONE; NORADRENALIN TRANSPORTER; SPIRONOLACTONE; SUCROSE; NERVE PROTEIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN LEVEL; CONTROLLED STUDY; DEPRESSION; ELEVATED T-MAZE TEST; ESCAPE BEHAVIOR; FRONTAL CORTEX; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HORMONAL REGULATION; IMMUNOFLUORESCENCE TEST; IN SITU HYBRIDIZATION; LOCUS CERULEUS; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STRESS; SUCROSE PREFERENCE TEST; TISSUE SPECIFICITY; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BIOSYNTHESIS; DOPAMINE Β-HYDROXYLASE; DRUG EFFECT; EXPLORATORY BEHAVIOR; FISCHER 344 RAT; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PSYCHOLOGICAL ASPECT; RAT; RAT BRAIN; TASTE; UPREGULATION;

ANIMALIA; RATTUS;

ANIMAL BEHAVIOR; CORTICOSTERONE; DOPAMINE Β-HYDROXYLASE; LOCUS COERULEUS; NOREPINEPHRINE TRANSPORTER; RAT BRAIN;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CORTICOSTERONE; DOPAMINE BETA-HYDROXYLASE; EXPLORATORY BEHAVIOR; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU HYBRIDIZATION; LOCUS COERULEUS; MALE; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, INBRED F344; RNA, MESSENGER; TASTE; UP-REGULATION;

EID: 84897018264     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12459     Document Type: Article

References (70)

1. Abercrombie E. D., and, Jacobs B. L., (1987) Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli. J. Neurosci. 7, 2837-2843.
2. Afar R., Silverman R., Aguanno A., and, Albert V. R., (1996) Positive and negative elements contribute to the cell-specific expression of the rat dopamine beta-hydroxylase gene. Brain Res. Mol. Brain Res. 36, 79-92.
3. Ahima R. S., and, Harlan R. E., (1990) Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 39, 579-604.
4. Ahima R. S., and, Harlan R. E., (1991) Differential corticosteroid regulation of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system: topography and implications. Endocrinology 129, 226-236.
5. Anisman H., and, Sklar L. S., (1979) Catecholamine depletion in mice upon reexposure to stress: mediation of the escape deficits produced by inescapable shock. J. Comp. Physiol. Psychol. 93, 610-625.
6. Auger C. J., and, Forbes-Lorman R. M., (2008) Progestin receptor-mediated reduction of anxiety-like behavior in male rats. PLoS ONE 3, e3606.
7. Bamberger C. M., Schulte H. M., and, Chrousos G. P., (1996) Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17, 245-261.
8. Barker E., and, Blakely R., (1995) Norepinephrine and serotonin transporters. Moleculartargets of antidepressant drugs, in Psychopharmacology. A fourth generation of progress, (, Bloom F., and, Kupfer D., eds.), pp. 321-333. Raven Press, New York.
9. Bitran D., Shiekh M., Dowd J. A., Dugan M. M., and, Renda P., (1998) Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors. Pharmacol. Biochem. Behav. 60, 879-887.
10. Brady L. S., (1994) Stress, antidepressant drugs, and the locus coeruleus. Brain Res. Bull. 35, 545-556.
11. Bunney W. E., Jr, and, Davis J. M., (1965) Norepinephrine in depressive reactions. A review. Arch. Gen. Psychiatry 13, 483-494.
12. Calfa G., Volosin M., and, Molina V. A., (2006) Glucocorticoid receptors in lateral septum are involved in the modulation of the emotional sequelae induced by social defeat. Behav. Brain Res. 172, 324-332.
13. Carboni E., Barros V. G., Ibba M., Silvagni A., Mura C., and, Antonelli M. C., (2010) Prenatal restraint stress: an in vivo microdialysis study on catecholamine release in the rat prefrontal cortex. Neuroscience 168, 156-166.
14. Carrasco G. A., and, Van de Kar L. D., (2003) Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463, 235-272.
15. Charney D. S., (1998) Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry 59 (Suppl 14), 11-14.
16. Chen P., Fan Y., Li Y., Sun Z., Bissette G., and, Zhu M. Y., (2012) Chronic social defeat up-regulates expression of norepinephrine transporter in rat brains. Neurochem. Int. 60, 9-20.
17. Cryan J. F., Dalvi A., Jin S. H., Hirsch B. R., Lucki I., and, Thomas S. A., (2001) Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J. Pharmacol. Exp. Ther. 298, 651-657.
18. Dallman M. F., Pecoraro N. C., La Fleur S. E., et al,. (2006) Glucocorticoids, chronic stress, and obesity. Prog. Brain Res. 153, 75-105.
19. De Vries T. J., Schoffelmeer A. N., Tjon G. H., Nestby P., Mulder A. H., and, Vanderschuren L. J., (1996) Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine. Eur. J. Pharmacol. 307, R3-R4.
20. Donner N. C., Montoya C. D., Lukkes J. L., and, Lowry C. A., (2012) Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression. Psychoneuroendocrinology 37, 645-661.
21. Fan Y., Chen P., Li Y., and, Zhu M. Y., (2013) Effects of chronic social defeat on expression of dopamine beta-hydroxylase in rat brains. Synapse 67, 300-312.
22. Friedman S., and, Kaufman S,. (1965) 3,4-Dihydroxyphenylethylamine Beta-Hydroxylase: a Copper Protein. J. Biol. Chem. 240, PC552-PC554.
23. Goddard A. W., Ball S. G., Martinez J., Robinson M. J., Yang C. R., Russell J. M., and, Shekhar A., (2010) Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety 27, 339-350.
24. Gourley S. L., and, Taylor J. R., (2009) Recapitulation and reversal of a persistent depression-like syndrome in rodents. Curr. Protoc. Neurosci. 49, 9.32.1-9.32.11.
25. Haller J., Millar S., and, Kruk M. R., (1998) Mineralocorticoid receptor blockade inhibits aggressive behaviour in male rats. Stress 2, 201-207.
26. Hlavacova N., Bakos J., and, Jezova D., (2010) Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release. J. Psychopharmacol. 24, 779-786.
27. Itoi K., (2008) Ablation of the central noradrenergic neurons for unraveling their roles in stress and anxiety. Ann. N. Y. Acad. Sci. 1129, 47-54.
28. Itoi K., and, Sugimoto N., (2010) The brainstem noradrenergic systems in stress, anxiety and depression. J. Neuroendocrinol. 22, 355-361.
29. Jacobsen J. P., and, Mork A., (2006) Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res. 1110, 221-225.
30. Jadavji N. M., Supina R. D., and, Metz G. A., (2011) Blockade of mineralocorticoid and glucocorticoid receptors reverses stress-induced motor impairments. Neuroendocrinology 94, 278-290.
31. Kabbaj M., Devine D. P., Savage V. R., and, Akil H., (2000) Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J. Neurosci. 20, 6983-6988.
32. Karatsoreos I. N., Bhagat S. M., Bowles N. P., Weil Z. M., Pfaff D. W., and, McEwen B. S., (2010) Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology 151, 2117-2127.
33. Kim C. H., Zabetian C. P., Cubells J. F., Cho S., Biaggioni I., Cohen B. M., Robertson D., and, Kim K. S., (2002) Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am. J. Med. Genet. 108, 140-147.
34. Kobayashi K., Morita S., Mizuguchi T., Sawada H., Yamada K., Nagatsu I., Fujita K., and, Nagatsu T., (1994) Functional and high level expression of human dopamine beta-hydroxylase in transgenic mice. J. Biol. Chem. 269, 29725-29731.
35. Korf J., Aghajanian G. K., and, Roth R. H., (1973) Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology 12, 933-938.
36. Korte S. M., de Boer S. F., de Kloet E. R., and, Bohus B., (1995) Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 20, 385-394.
37. Kvetnansky R., Krizanova O., Tillinger A., Sabban E. L., Thomas S. A., and, Kubovcakova L., (2008) Regulation of gene expression of catecholamine biosynthetic enzymes in dopamine-beta-hydroxylase- and CRH-knockout mice exposed to stress. Ann. N. Y. Acad. Sci. 1148, 257-268.
38. Kwon M. S., Seo Y. J., Choi S. M., Choi H. W., Jung J. S., Park S. H., and, Suh H. W., (2007) The differential effects of single or repeated restraint stress on kainic acid-induced neuronal death in the hippocampal CA3 region: the role of glucocorticoid and various signal molecules. J. Neurochem. 103, 1530-1541.
39. Li L. F., Lu J., Li X. M., Xu C. L., Deng J. M., Qu R., and, Ma S. P., (2012) Antidepressant-like effect of magnolol on BDNF up-regulation and serotonergic system activity in unpredictable chronic mild stress treated rats. Phytother. Res. 26, 1189-1194.
40. Macunluoglu B., Arikan H., Atakan A., Tuglular S., Ulfer G., Cakalagaoglu F., Ozener C., and, Akoglu E., (2008) Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity. Transpl. Proc. 40, 273-278.
41. Magarinos A. M., Orchinik M., and, McEwen B. S., (1998) Morphological changes in the hippocampal CA3 region induced by non-invasive glucocorticoid administration: a paradox. Brain Res. 809, 314-318.
42. Mao Q. Q., Huang Z., Zhong X. M., Feng C. R., Pan A. J., Li Z. Y., Ip S. P., and, Che C. T., (2010) Effects of SYJN, a Chinese herbal formula, on chronic unpredictable stress-induced changes in behavior and brain BDNF in rats. J. Ethnopharmacol. 128, 336-341.
43. Marino M. D., Bourdelat-Parks B. N., Cameron Liles L., and, Weinshenker D., (2005) Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice. Behav. Brain Res. 161, 197-203.
44. Mason S. T., and, Fibiger H. C., (1979) Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase. J. Comp. Neurol. 187, 703-724.
45. McEwen B. S., (1999) Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22, 105-122.
46. Nacher J., Gomez-Climent M. A., and, McEwen B., (2004a) Chronic non-invasive glucocorticoid administration decreases polysialylated neural cell adhesion molecule expression in the adult rat dentate gyrus. Neurosci. Lett. 370, 40-44.
47. Nacher J., Pham K., Gil-Fernandez V., and, McEwen B. S., (2004b) Chronic restraint stress and chronic corticosterone treatment modulate differentially the expression of molecules related to structural plasticity in the adult rat piriform cortex. Neuroscience 126, 503-509.
48. Ni H., Mune T., Morita H., Daidoh H., Hanafusa J., Shibata T., Yamakita N., and, Yasuda K., (1995) Inhibition of aldosterone turn-off phenomenon following chronic adrenocorticotropin treatment with in vivo administration of antiglucocorticoid and antioxidants in rats. Eur. J. Endocrinol. 133, 578-584.
49. Pacak K., Palkovits M., Kopin I. J., and, Goldstein D. S., (1995) Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front. Neuroendocrinol. 16, 89-150.
50. Papp M., Willner P., and, Muscat R., (1991) An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104, 255-259.
51. Paxinos G., and, Watson C., (2005) The rat brain in stereotaxic coordinates. Elsevier, Oxford, UK.
52. Ramos A., (2008) Animal models of anxiety: do I need multiple tests? Trends Pharmacol. Sci. 29, 493-498.
53. Ratka A., Sutanto W., Bloemers M., and, de Kloet E. R., (1989) On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50, 117-123.
54. Ritter S., Llewellyn-Smith I., and, Dinh T. T., (1998) Subgroups of hindbrain catecholamine neurons are selectively activated by 2-deoxy-D-glucose induced metabolic challenge. Brain Res. 805, 41-54.
55. Roceri M., Cirulli F., Pessina C., Peretto P., Racagni G., and, Riva M. A., (2004) Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol. Psychiatry 55, 708-714.
56. Roland B. L., Krozowski Z. S., and, Funder J. W., (1995) Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Mol. Cell. Endocrinol. 111, R1-R7.
57. Rosario L. A., and, Abercrombie E. D., (1999) Individual differences in behavioral reactivity: correlation with stress-induced norepinephrine efflux in the hippocampus of Sprague-Dawley rats. Brain Res. Bull. 48, 595-602.
58. Sabban E. L., (2007) Catecholamines in stress: molecular mechanisms of gene expression. Endocr. Regul. 41, 61-73.
59. Sapolsky R. M., (1996) Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion. Stress 1, 1-19.
60. Sapolsky R., Brooke S., and, Stein-Behrens B., (1995) Methodologic issues in studying glucocorticoid-induced damage to neurons. J. Neurosci. Methods 58, 1-15.
61. Schatzberg A. F., and, Schildkraut J. J,. (1995) Recent studies on norepinephrine systems in mood disorders,in Psychopharmacology: the Fourth Generation of Progress (, Bloom F. E., and, Kupfer D. J., eds), pp. 911-920. Raven Press Ltd., New York.
62. Schroeter S., Apparsundaram S., Wiley R. G., Miner L. H., Sesack S. R., and, Blakely R. D., (2000) Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J. Comp. Neurol. 420, 211-232.
63. Shaskus J., Greco D., Asnani L. P., and, Lewis E. J., (1992) A bifunctional genetic regulatory element of the rat dopamine beta-hydroxylase gene influences cell type specificity and second messenger-mediated transcription. J. Biol. Chem. 267, 18821-18830.
64. Smagin G. N., Zhou J., Harris R. B., and, Ryan D. H., (1997) CRF receptor antagonist attenuates immobilization stress-induced norepinephrine release in the prefrontal cortex in rats. Brain Res. Bull. 42, 431-434.
65. Smythe J. W., Murphy D., Timothy C., and, Costall B., (1997) Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol. Biochem. Behav. 56, 507-513.
66. Thomson F., and, Craighead M., (2008) Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem. Res. 33, 691-707.
67. Trivedi M. A., and, Coover G. D., (2004) Lesions of the ventral hippocampus, but not the dorsal hippocampus, impair conditioned fear expression and inhibitory avoidance on the elevated T-maze. Neurobiol. Learn. Mem. 81, 172-184.
68. Weiss J. M., Bailey W. H., Pohorecky L. A., Korzeniowski D., and, Grillione G., (1980) Stress-induced depression of motor activity correlates with regional changes in brain norepinephrine but not in dopamine. Neurochem. Res. 5, 9-22.
69. Willner P., Towell A., Sampson D., Sophokleous S., and, Muscat R., (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93, 358-364.
70. Zhu M. Y., Kim C. H., Hwang D. Y., Baldessarini R. J., and, Kim K. S., (2002) Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue. J. Neurochem. 82, 146-153.